← Leaderboards
Harvey Rubin
University Of Pennsylvania
$4,989,296
Attributed
$4,989,296
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $630.6K · FY2007–20$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,989,296 · 4
By mechanism
R01$4,546,546 · 3
R21$442,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Holger Willenbring$13,377,791
- Rashmin C Savani$8,890,174
- Kenneth J McLaughlin$1,801,345
- Rohan Palanki$178,372
- Edward E Morrisey$54,694,196
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisMutantBaseMutationEnzyme MechanismGrowthDesignPhenotypeBacteriaEnzyme InhibitorsDeletion AnalysisAffinityCrosslinkEnzyme Inhibitor DrugsEnzyme InhibitionDrug ResistanceAnalogComplexElectrical PotentialCalmette-Guerin BacillusBioenergeticsComplementBiochemistryDeuterium
Grant awards (16)
The Role of Bet Hedging Strategies in Bacterial Adaptation$201,250
R21 · FY2020 · AI · contact PI
The Role of Bet Hedging Strategies in Bacterial Adaptation$241,500
R21 · FY2019 · AI · contact PI
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis$377,631
R01 · FY2011 · AI · contact PI
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis$381,444
R01 · FY2010 · AI · contact PI
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis$249,117
R01 · FY2010 · AI · contact PI
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis$376,974
R01 · FY2009 · AI · contact PI
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis$368,894
R01 · FY2008 · AI · contact PI
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis$382,417
R01 · FY2007 · AI · contact PI
SERINE PROTEASE INHIBITORS &MECHANISMS OF INFLAMATION$168,238
R01 · FY2004 · HL
REGULATION OF DORMANCY IN M TUBERCULOSIS$387,951
R01 · FY2003 · AI
REGULATION OF DORMANCY IN M TUBERCULOSIS$324,457
R01 · FY2002 · AI
SERINE PROTEASE INHIBITORS &MECHANISMS OF INFLAMATION$310,305
R01 · FY2002 · HL
REGULATION OF DORMANCY IN M TUBERCULOSIS$315,007
R01 · FY2001 · AI
SERINE PROTEASE INHIBITORS &MECHANISMS OF INFLAMATION$302,787
R01 · FY2001 · HL
REGULATION OF DORMANCY IN M TUBERCULOSIS$305,836
R01 · FY2000 · AI
SERINE PROTEASE INHIBITORS &MECHANISMS OF INFLAMATION$295,488
R01 · FY2000 · HL